ModivCare

Medicare Reimbursement Cuts And Digital Rivals Will Weaken Revenues

AnalystLowTarget

Not Invested

Community Contributor

Published

14 Aug 25

AnalystLowTarget's Fair Value

US$1.20

85.2% undervalued

14 Aug

US$0.18

-98.7%

-19.1%

-98.7%

-19.1%

You can edit this narrative until Aug 14 10:20 PM. Then, changes will post as Updates.

Author's Valuation

US$1.2

85.2% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

US$1.2

85.2% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

0.00%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

12.32%

Calculation

US$159.74m

Earnings '28

0.16x

PE Ratio '28

US$25.00m

Market Cap '28

US$25.00m

Market Cap '28

14.70m

No. shares '28

US$1.70

Share Price '28

US$1.70 Share Price '28

Discounted to 2025 @ 12.32% p.a.

US$1.20

Fair Value '25